Get access to our best features
Get Started
Subscribe
Get access to our best features
Get Started
Published 2 months ago

Comparing two plasma p-tau217 assays for Alzheimer's detection and monitoring

Summary by News Medical
Researchers compared two commercially available blood tests based on the biomarker p-tau217 for diagnosing Alzheimer's disease in 294 patients. Both tests demonstrated robust diagnostic capabilities, strongly correlating with established Alzheimer's biomarkers from PET scans.
More
Filters

1 Articles

All
Left
Center
Right
News MedicalNews Medical

Comparing two plasma p-tau217 assays for Alzheimer's detection and monitoring

Researchers compared two commercially available blood tests based on the biomarker p-tau217 for diagnosing Alzheimer's disease in 294 patients. Both tests demonstrated robust diagnostic capabilities, strongly correlating with established Alzheimer's biomarkers from PET scans.

2 months ago·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

AlzheimerAlzheimer
Alzheimer's DiseaseAlzheimer's Disease
MedicalMedical
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsSubscribeGiftFree TrialCareersFor Educators/LibrariesAffiliates
HelpHelp CenterFAQContact UsMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsBrowser ExtensionRehashDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyTerms and Conditions
© 2023 Snapwise Inc.
News
For You
Search
BlindspotLocal